There are 702 resources available
Conclusions and Q&A
Presenter: Maria Alsina Maqueda
Session: BeiGene - Advances in upper GI immunotherapy: What’s new on the horizon?
Resources:
Webcast
Surgery and NET
Presenter: Detlef Bartsch
Session: GEP NET
Resources:
Slides
Webcast
PRRT and NET
Presenter: Désirée de Andreis
Session: GEP NET
Resources:
Slides
Webcast
Medical treatment of NET
Presenter: Rachel Riechelmann
Session: GEP NET
Resources:
Slides
Webcast
Strategy of the treatment of localised and advanced NET
Presenter: Chris Verslype
Session: GEP NET
Resources:
Slides
Webcast
Q&A
Session: GEP NET
Resources:
Webcast
279MO - Three-year survival, safety and extended long-term survivor (eLTS) analysis from the phase III TOPAZ-1 study of durvalumab (D) plus chemotherapy in biliary tract cancer (BTC)
Presenter: Do-Youn Oh
Session: Mini Oral session 3
Resources:
Abstract
Slides
Webcast
280MO - CD40 agonist mitazalimab combined with mFOLFIRINOX (mFFX) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Primary analysis of the OPTIMIZE-1 phase Ib/II study
Presenter: Teresa Macarulla Mercade
Session: Mini Oral session 3
Resources:
Abstract
Slides
Webcast
Invited discussant abstracts 279MO and 280MO
Presenter: Zev Wainberg
Session: Mini Oral session 3
Resources:
Slides
Webcast
Q&A and discussion
Session: Mini Oral session 3
Resources:
Webcast